Osiris Therapeutics, Inc. Company Information
Employees at Osiris Therapeutics, Inc.
Showing 15 of 374| JOB TITLE | WORK EMAIL | WORK PHONE | LOCATION | |
|---|---|---|---|---|
| Marketing Assistant | Vakili, Khorasan-E Razavi | |||
| Manufacturing Associate Ii | California | |||
| Assistant Director, Clinical Research and Operations | Washington, District Of Columbia | |||
| Employee | Washington, District Of Columbia | |||
| Senior Manager, Gene Delivery | Baltimore, Maryland | |||
| Employee | Baltimore, Maryland | |||
| Administradora Unica | ||||
| Employee | Chapin, South Carolina | |||
| Regional Sales Specialist | Seabold, Washington | |||
| Chemist | Baltimore, Maryland | |||
| Stem Cell Therapy Associate | Baltimore, Maryland | |||
| Regional Sales Specialist | Raleigh, North Carolina | |||
| Donor Eligibility Associate | Maryland | |||
| Scientist and Program Manager, Prochymal For Ars | Washington, District Of Columbia | |||
| Tissue Processing Technician | Washington |
Marketing Assistant
Vakili, Khorasan-E Razavi Manufacturing Associate Ii
California Assistant Director, Clinical Research and Operations
Washington, District Of Columbia Employee
Washington, District Of Columbia Senior Manager, Gene Delivery
Baltimore, Maryland Employee
Baltimore, Maryland Administradora Unica
Employee
Chapin, South Carolina Regional Sales Specialist
Seabold, Washington Chemist
Baltimore, Maryland Stem Cell Therapy Associate
Baltimore, Maryland Regional Sales Specialist
Raleigh, North Carolina Donor Eligibility Associate
Maryland Scientist and Program Manager, Prochymal For Ars
Washington, District Of Columbia Tissue Processing Technician
Washington Enter an employee name to search and verify work emails, phone numbers and social links etc.
Osiris Therapeutics, Inc.'s Email Format
We found 4 email formats used by Osiris Therapeutics, Inc. employees. The most common Osiris Therapeutics, Inc. email format is first_initial last ex.(jdoe@osiris.com) being used 95% of the time.
first_initial last
95%
first
2%
others
2%
first last
1%